Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer

Javier Cortes, Alberto J. Montero, Stefan Glück

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences